Profiel
Dr. Alexandre Kaoukhov is a Chief Medical Officer at Aslan Pharmaceuticals Ltd. Dr. Kaoukhov was previously employed as a Senior Vice President & Head-Clinical Development by Bioniz Therapeutics, Inc., a Head-Global Development by Almirall SA, and a Head-Global Development by Allergan, Inc. He received his doctorate degree from I.M.
Sechenov First Moscow State Medical University.
Actieve functies van Alexandre Kaoukhov
| Bedrijven | Functie | Begin |
|---|---|---|
| ASLAN PHARMACEUTICALS LIMITED | Hoofd Techniek/Wetenschap/O&O | 15-03-2022 |
Eerdere bekende functies van Alexandre Kaoukhov
| Bedrijven | Functie | Einde |
|---|---|---|
Bioniz Therapeutics, Inc.
Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage biotechnology company | Corporate Officer/Principal | - |
| ALMIRALL, S.A. | Corporate Officer/Principal | 01-11-2020 |
| ALLERGAN, INC. | Corporate Officer/Principal | 01-01-2018 |
Opleiding van Alexandre Kaoukhov
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Almirall SA
Almirall SA Pharmaceuticals: MajorHealth Technology Engages in the development, manufacture and sale of pharmaceuticals | Health Technology |
Bioniz Therapeutics, Inc.
Bioniz Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage biotechnology company | Commercial Services |
I.M. Sechenov First Moscow State Medical University
I.M. Sechenov First Moscow State Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aslan Pharmaceuticals Ltd.
Aslan Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as biotechnology company which develops immuno-oncology agents and targeted therapies | Health Technology |
















